RCMNY
Rubric Capital Management (New York) Portfolio holdings
AUM
$6.22B
This Quarter Return
-14.58%
1 Year Return
+46.93%
3 Year Return
+140.96%
5 Year Return
+327.45%
10 Year Return
–
AUM
$1.9B
AUM Growth
+$1.9B
(-11%)
Cap. Flow
+$75.2M
Cap. Flow
% of AUM
3.95%
Top 10 Holdings %
Top 10 Hldgs %
43.35%
Holding
99
New
27
Increased
21
Reduced
6
Closed
9
Top Buys
| 1 |
WillScot Mobile Mini Holdings
WSC
|
$42.8M |
| 2 |
BRSL
Brightstar Lottery PLC
BRSL
|
$23.9M |
| 3 |
Apollo Global Management
APO
|
$22.1M |
| 4 |
Mr. Cooper
COOP
|
$20M |
| 5 |
Insmed
INSM
|
$12.7M |
Top Sells
| 1 |
ATRS
Antares Pharma, Inc.
ATRS
|
$44.7M |
| 2 |
New Fortress Energy
NFE
|
$33.8M |
| 3 |
Chegg
CHGG
|
$33.4M |
| 4 |
AAR Corp
AIR
|
$19.3M |
| 5 |
FerroAtlántica
GSM
|
$11.9M |
Sector Composition
| 1 | Healthcare | 22.91% |
| 2 | Industrials | 18.53% |
| 3 | Energy | 12.47% |
| 4 | Financials | 10.45% |
| 5 | Consumer Discretionary | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Advantage Solutions
ADV
$551M
| $7.18M | 0.38% |
1,889,574
| – | – |
|
52
Regenxbio
RGNX
$498M
| $7.1M | 0.37% |
+287,467
| New | +$7.1M |
|
|
SWIR
53
DELISTED
Sierra Wireless
SWIR
| $6.92M | 0.36% |
295,683
| – | – |
|
54
MediaAlpha
MAX
$613M
| $6.25M | 0.33% |
634,579
| – | – |
|
55
Ovid Therapeutics
OVID
$94.6M
| $6.2M | 0.33% |
+2,882,706
| New | +$6.2M |
|
56
Krystal Biotech
KRYS
$4.35B
| $6.08M | 0.32% |
+92,609
| New | +$6.08M |
|
|
AVEO
57
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $6.06M | 0.32% |
+923,885
| New | +$6.06M |
|
58
Invivyd
IVVD
$218M
| $5.94M | 0.31% |
+1,812,347
| New | +$5.94M |
|
59
BioXcel Therapeutics
BTAI
$52.7M
| $5.17M | 0.27% |
391,650
+123,122
| +46% | +$1.63M |
|
60
Kiniksa Pharmaceuticals
KNSA
$2.63B
| $5.07M | 0.27% |
+523,528
| New | +$5.07M |
|
61
Trevi Therapeutics
TRVI
$871M
| $5M | 0.26% |
+1,778,420
| New | +$5M |
|
62
Arcutis Biotherapeutics
ARQT
$1.91B
| $4.82M | 0.25% |
+226,346
| New | +$4.82M |
|
63
ATAI Life Sciences
ATAI
$969M
| $4.8M | 0.25% |
+1,319,137
| New | +$4.8M |
|
64
Sutro Biopharma
STRO
$85.6M
| $4.69M | 0.25% |
+900,000
| New | +$4.69M |
|
65
CytomX Therapeutics
CTMX
$350M
| $4.4M | 0.23% |
2,406,449
| – | – |
|
66
Precision BioSciences
DTIL
$59.5M
| $4.25M | 0.22% |
+2,657,115
| New | +$4.25M |
|
67
ARS Pharmaceuticals
SPRY
$1.08B
| $4.18M | 0.22% |
+986,453
| New | +$4.18M |
|
68
Cullinan Oncology
CGEM
$456M
| $3.81M | 0.2% |
+297,347
| New | +$3.81M |
|
|
TSVT
69
DELISTED
2seventy bio
TSVT
| $3.5M | 0.18% |
+265,000
| New | +$3.5M |
|
70
Xoma
XOMA
$421M
| $3.33M | 0.17% |
+149,446
| New | +$3.33M |
|
71
Cellebrite
CLBT
$4.04B
| $3.21M | 0.17% |
629,020
| – | – |
|
|
CMPS
72
Compass Pathways
CMPS
$452M
| $3.07M | 0.16% |
+283,694
| New | +$3.07M |
|
73
Tarsus Pharmaceuticals
TARS
$2.44B
| $2.96M | 0.16% |
+202,648
| New | +$2.96M |
|
|
VINC
74
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $2.78M | 0.15% |
2,107,000
| – | – |
|
75
ANI Pharmaceuticals
ANIP
$2.06B
| $2.45M | 0.13% |
+82,444
| New | +$2.45M |
|